Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Long-Term Investments (2021 - 2025)

Bio Key International's Long-Term Investments history spans 4 years, with the latest figure at $5.0 million for Q3 2025.

  • For Q3 2025, Long-Term Investments changed N/A year-over-year to $5.0 million; the TTM value through Sep 2025 reached $5.0 million, changed N/A, while the annual FY2024 figure was $5.0 million, N/A changed from the prior year.
  • Long-Term Investments for Q3 2025 was $5.0 million at Bio Key International, roughly flat from $5.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $5.0 million in Q4 2024 and bottomed at $262821.0 in Q3 2022.
  • The 4-year median for Long-Term Investments is $482821.0 (2021), against an average of $2.4 million.
  • The largest YoY upside for Long-Term Investments was 45.57% in 2022 against a maximum downside of 45.57% in 2022.
  • A 4-year view of Long-Term Investments shows it stood at $452821.0 in 2021, then crashed by 41.96% to $262821.0 in 2022, then soared by 1802.44% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Long-Term Investments are $5.0 million (Q3 2025), $5.0 million (Q2 2025), and $5.0 million (Q1 2025).